健帆生物主营产品

Search documents
健帆生物(300529.SZ):上半年净利润3.9亿元 同比下降29.46%
Ge Long Hui A P P· 2025-08-21 12:25
Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025, attributed to a high base from the previous year and a strategic price reduction to boost sales volume [1] Financial Performance - The company achieved a revenue of 1.134 billion yuan in the first half of 2025, representing a year-on-year decrease of 24.15% [1] - The net profit attributable to shareholders was 390 million yuan, down 29.46% compared to the same period last year [1] Strategic Actions - In the previous year, the company reduced the terminal prices of its main products by 26% to increase sales volume, which resulted in a high comparative base for this year's performance [1] - The company has strengthened channel management, leading to a reduction in accounts receivable to 25.03 million yuan, a decrease of 53% from the beginning of the period [1]